On April 1, 2025, GRI Bio, Inc. announced a public offering of 202,000 shares and various warrants, expecting to raise about $4.2 million for working capital and product development. The offering is set to close around April 2, 2025, with specific terms regarding the warrants and restrictions on future stock issuance.